Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Apr 1;99(7):1786–1797. doi: 10.1172/JCI119343

A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.

I Inoue 1, T Nakajima 1, C S Williams 1, J Quackenbush 1, R Puryear 1, M Powers 1, T Cheng 1, E H Ludwig 1, A M Sharma 1, A Hata 1, X Jeunemaitre 1, J M Lalouel 1
PMCID: PMC508000  PMID: 9120024

Abstract

In earlier studies, we provided statistical evidence that individual differences in the angiotensinogen gene, the precursor of the vasoactive hormone angiotensin II, constitute inherited predispositions to essential hypertension in humans. We have now identified a common variant in the proximal promoter, the presence of an adenine, instead of a guanine, 6 bp upstream from the initiation site of transcription, in significant association with the disorder. Tests of promoter activity and DNA binding studies with nuclear proteins suggest that this nucleotide substitution affects the basal transcription rate of the gene. These observations provide some biological insight about the possible mechanism of a genetic predisposition to essential hypertension; they may also have important evolutionary implications.

Full Text

The Full Text of this article is available as a PDF (447.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arngrímsson R., Purandare S., Connor M., Walker J. J., Björnsson S., Soubrier F., Kotelevtsev Y. V., Geirsson R. T., Björnsson H. Angiotensinogen: a candidate gene involved in preeclampsia? Nat Genet. 1993 Jun;4(2):114–115. doi: 10.1038/ng0693-114. [DOI] [PubMed] [Google Scholar]
  2. Bloem L. J., Manatunga A. K., Tewksbury D. A., Pratt J. H. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995 Mar;95(3):948–953. doi: 10.1172/JCI117803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Campbell D. J., Habener J. F. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest. 1986 Jul;78(1):31–39. doi: 10.1172/JCI112566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Campbell D. J. Tissue renin-angiotensin system: sites of angiotensin formation. J Cardiovasc Pharmacol. 1987;10 (Suppl 7):S1–S8. doi: 10.1097/00005344-198706107-00002. [DOI] [PubMed] [Google Scholar]
  5. Denton D., Weisinger R., Mundy N. I., Wickings E. J., Dixson A., Moisson P., Pingard A. M., Shade R., Carey D., Ardaillou R. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995 Oct;1(10):1009–1016. doi: 10.1038/nm1095-1009. [DOI] [PubMed] [Google Scholar]
  6. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dyer A. R., Stamler R., Elliott P., Stamler J. Dietary salt and blood pressure. Nat Med. 1995 Oct;1(10):994–996. doi: 10.1038/nm1095-994. [DOI] [PubMed] [Google Scholar]
  8. Fernandez J., DeMott M., Atherton D., Mische S. M. Internal protein sequence analysis: enzymatic digestion for less than 10 micrograms of protein bound to polyvinylidene difluoride or nitrocellulose membranes. Anal Biochem. 1992 Mar;201(2):255–264. doi: 10.1016/0003-2697(92)90336-6. [DOI] [PubMed] [Google Scholar]
  9. Fukamizu A., Takahashi S., Seo M. S., Tada M., Tanimoto K., Uehara S., Murakami K. Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter. J Biol Chem. 1990 May 5;265(13):7576–7582. [PubMed] [Google Scholar]
  10. Hata A., Namikawa C., Sasaki M., Sato K., Nakamura T., Tamura K., Lalouel J. M. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 1994 Mar;93(3):1285–1287. doi: 10.1172/JCI117083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ho S. N., Hunt H. D., Horton R. M., Pullen J. K., Pease L. R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989 Apr 15;77(1):51–59. doi: 10.1016/0378-1119(89)90358-2. [DOI] [PubMed] [Google Scholar]
  12. Hopkins P. N., Lifton R. P., Hollenberg N. K., Jeunemaitre X., Hallouin M. C., Skuppin J., Williams C. S., Dluhy R. G., Lalouel J. M., Williams R. R. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens. 1996 Feb;14(2):199–207. doi: 10.1097/00004872-199602000-00008. [DOI] [PubMed] [Google Scholar]
  13. Inoue I., Rohrwasser A., Helin C., Jeunemaitre X., Crain P., Bohlender J., Lifton R. P., Corvol P., Ward K., Lalouel J. M. A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem. 1995 May 12;270(19):11430–11436. doi: 10.1074/jbc.270.19.11430. [DOI] [PubMed] [Google Scholar]
  14. Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A., Hunt S. C., Hopkins P. N., Williams R. R., Lalouel J. M. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992 Oct 2;71(1):169–180. doi: 10.1016/0092-8674(92)90275-h. [DOI] [PubMed] [Google Scholar]
  15. Kim H. S., Krege J. H., Kluckman K. D., Hagaman J. R., Hodgin J. B., Best C. F., Jennette J. C., Coffman T. M., Maeda N., Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2735–2739. doi: 10.1073/pnas.92.7.2735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lifton R. P., Dluhy R. G., Powers M., Rich G. M., Cook S., Ulick S., Lalouel J. M. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992 Jan 16;355(6357):262–265. doi: 10.1038/355262a0. [DOI] [PubMed] [Google Scholar]
  17. Loebermann H., Tokuoka R., Deisenhofer J., Huber R. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol. 1984 Aug 15;177(3):531–557. [PubMed] [Google Scholar]
  18. Mimori T., Hardin J. A. Mechanism of interaction between Ku protein and DNA. J Biol Chem. 1986 Aug 5;261(22):10375–10379. [PubMed] [Google Scholar]
  19. Mune T., Rogerson F. M., Nikkilä H., Agarwal A. K., White P. C. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet. 1995 Aug;10(4):394–399. doi: 10.1038/ng0895-394. [DOI] [PubMed] [Google Scholar]
  20. NEEL J. V. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962 Dec;14:353–362. [PMC free article] [PubMed] [Google Scholar]
  21. Reeves W. H., Sthoeger Z. M. Molecular cloning of cDNA encoding the p70 (Ku) lupus autoantigen. J Biol Chem. 1989 Mar 25;264(9):5047–5052. [PubMed] [Google Scholar]
  22. Rust S., Funke H., Assmann G. Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res. 1993 Aug 11;21(16):3623–3629. doi: 10.1093/nar/21.16.3623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Schreiber E., Matthias P., Müller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989 Aug 11;17(15):6419–6419. doi: 10.1093/nar/17.15.6419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shepherd N. S., Pfrogner B. D., Coulby J. N., Ackerman S. L., Vaidyanathan G., Sauer R. H., Balkenhol T. C., Sternberg N. Preparation and screening of an arrayed human genomic library generated with the P1 cloning system. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2629–2633. doi: 10.1073/pnas.91.7.2629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shimkets R. A., Warnock D. G., Bositis C. M., Nelson-Williams C., Hansson J. H., Schambelan M., Gill J. R., Jr, Ulick S., Milora R. V., Findling J. W. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994 Nov 4;79(3):407–414. doi: 10.1016/0092-8674(94)90250-x. [DOI] [PubMed] [Google Scholar]
  26. Smithies O., Kim H. S. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3612–3615. doi: 10.1073/pnas.91.9.3612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tamura K., Umemura S., Ishii M., Tanimoto K., Murakami K., Fukamizu A. Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter. J Clin Invest. 1994 Apr;93(4):1370–1379. doi: 10.1172/JCI117113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Volpe P., Iacovacci P., Butler R. H., Eremenko T. 5-Methylcytosine in genes with methylation-dependent regulation. FEBS Lett. 1993 Aug 30;329(3):233–237. doi: 10.1016/0014-5793(93)80228-m. [DOI] [PubMed] [Google Scholar]
  29. Ward K., Hata A., Jeunemaitre X., Helin C., Nelson L., Namikawa C., Farrington P. F., Ogasawara M., Suzumori K., Tomoda S. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 1993 May;4(1):59–61. doi: 10.1038/ng0593-59. [DOI] [PubMed] [Google Scholar]
  30. Yanai K., Nibu Y., Murakami K., Fukamizu A. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem. 1996 Jul 5;271(27):15981–15986. doi: 10.1074/jbc.271.27.15981. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES